New derivatives of silybin and 2,3-dehydrosilybin and their cytotoxic and P-glycoprotein modulatory activity
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388971%3A_____%2F06%3A00043280" target="_blank" >RIV/61388971:_____/06:00043280 - isvavai.cz</a>
Alternative codes found
RIV/61989592:15110/06:00002756
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
New derivatives of silybin and 2,3-dehydrosilybin and their cytotoxic and P-glycoprotein modulatory activity
Original language description
Large series of O-alkyl derivatives of silybin and 2,3-dehydrosilybin was prepared. All prepared silybin/2,3-dehydrosilybin derivatives were tested for cytotoxicity on a panel of drugs sensitive against multidrug resistant cell lines and the ability to inhibit P-glycoprotein mediated efflux activity. We have identified effective and relatively non-cytotoxic inhibitors of P-gp derived from 2,3-dehydrosilybin. Some of them were more effective inhibitors than a standard P-gp efflux inhibitor cyclosporin A.In the frame of this study were established structural requirements for improving inhibitory activity and reducing toxicity of 2,3-dehydrosilybin as well
Czech name
Nové deriváty silybinu a 2,3-dehydrosilybinu - jejich cytotoxicita a P-glykoprotein modulační aktivita
Czech description
Byla připravena řada selektivně alkylovaných derivátů silybinu a 2,3-dehydrosilybinu určených pro strukturně-aktivitní studie jejich efektu na inhibici effluxní funkce P-glykoproteinu. Připravené deriváty silybinu/2,3-dehydrosilybinu byly testovány rovněž na cytotoxicitu v panelu buněk citlivých a rezistentních k léčivu. Identifikovali jsme efektivní a relativně netoxické inhibitory P-gp odvozené od 2,3-dehydrosilybinu. Řada z nich vykazovala lepší inhibiční aktivitu než standardní P-gp inhibitor cyklosporin A. V rámci této studie byly také stanoveny strukturní požadavky pro zlepšení inhibiční aktivity a snížení toxicity 2,3-dehydrosilybinu
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
EE - Microbiology, virology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/GA303%2F02%2F1097" target="_blank" >GA303/02/1097: Synthesis and Biological Characterization of New Compounds Derived from Silibinin for Potential Use as Chemoprotectants in Dermatology</a><br>
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2006
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Bioorganic Medical Chemistry
ISSN
0968-0896
e-ISSN
—
Volume of the periodical
14
Issue of the periodical within the volume
-
Country of publishing house
GB - UNITED KINGDOM
Number of pages
8
Pages from-to
3793-3810
UT code for WoS article
—
EID of the result in the Scopus database
—